Target Actionability Review: a systematic evaluation of replication stress as a therapeutic target for paediatric solid malignancies-Reference-Cited by-同舟云学术

Target Actionability Review: a systematic evaluation of replication stress as a therapeutic target for paediatric solid malignancies

Published:2022-02 Issue: Volume:162 Page:107-117
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Keller Kaylee M.,Krausert Sonja^ORCID,Gopisetty Apurva,Luedtke Dan^ORCID,Koster Jan^ORCID,Schubert Nil A.^ORCID,Rodríguez Ana,van Hooff Sander R.,Stichel Damian^ORCID,Dolman M. Emmy M.,Vassal Gilles,Pfister Stefan M.^ORCID,Caron Hubert N.,Stancato Louis F.,Molenaar Jan J.,Jäger Natalie,Kool Marcel

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference33 articles.

1. Improving the outcome for children with cancer: development of targeted new agents;Adamson;CA A Cancer J Clin,2015

2. Cancer statistics, 2019;Siegel;CA A Cancer J Clin,2019

3. Systematic target actionability reviews of preclinical proof-of-concept papers to match targeted drugs to paediatric cancers;Schubert;Eur J Cancer,2020

4. The role of the “innovative therapies for children with cancer” (ITCC) European consortium;Zwaan;Cancer Treat Rev,2010

5. Recovery from DNA replicational stress is the essential function of the S-phase checkpoint pathway;Desany;Genes Dev,1998

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CDK12 controls transcription at damaged genes and prevents MYC-induced transcription-replication conflicts;Nature Communications;2024-08-18

2. Identification and validation of miRNA-target genes network in pediatric brain tumors;Scientific Reports;2024-08-02

3. CDK12 controls transcription at damaged genes and prevents MYC-induced transcription-replication conflicts;2024-06-03

4. Therapeutic Targeting of DNA Repair Pathways in Pediatric Extracranial Solid Tumors: Current State and Implications for Immunotherapy;Cancers;2024-04-25

5. Preclinical exploration of the DNA damage response pathway using the interactive neuroblastoma cell line explorer CLEAN;NAR Cancer;2024-01-09